loadpatents
Patent applications and USPTO patent grants for WAIN-HOBSON; Simon.The latest application filed is for "polyepitope constructs for use in immunotherapy".
Patent | Date |
---|---|
Polyepitope Constructs For Use In Immunotherapy App 20210254098 - LANGLADE DEMOYEN; Pierre ;   et al. | 2021-08-19 |
Cancer vaccine for cats Grant 10,675,337 - Langlade Demoyen , et al. | 2020-06-09 |
Cancer Vaccine For Dogs App 20190177733 - LANGLADE DEMOYEN; Pierre ;   et al. | 2019-06-13 |
Telomerase encoding DNA vaccine Grant 10,183,065 - Langlade Demoyen , et al. Ja | 2019-01-22 |
Telomerase Encoding Dna Vaccine App 20190000946 - Langlade Demoyen; Pierre ;   et al. | 2019-01-03 |
Cancer vaccine for dogs Grant 10,138,488 - Langlade Demoyen , et al. Nov | 2018-11-27 |
Cancer Vaccine For Cats App 20180271963 - LANGLADE DEMOYEN; Pierre ;   et al. | 2018-09-27 |
Polyepitope Constructs For Use In Immunotherapy App 20180251781 - LANGLADE DEMOYEN; Pierre ;   et al. | 2018-09-06 |
Method of treating fibrosarcoma using a nucleic acid sequence encoding APOBEC3A Grant 10,010,591 - Langlade Demoyen , et al. July 3, 2 | 2018-07-03 |
Cancer vaccine for cats Grant 9,931,387 - Langlade Demoyen , et al. April 3, 2 | 2018-04-03 |
Telomerase Encoding Dna Vaccine App 20160263204 - Langlade Demoyen; Pierre ;   et al. | 2016-09-15 |
Apobec3a As An Anti-tumor Agent App 20160120962 - LANGLADE DEMOYEN; Pierre ;   et al. | 2016-05-05 |
A Cancer Vaccine For Cats App 20160051650 - LANGLADE DEMOYEN; Pierre ;   et al. | 2016-02-25 |
A Cancer Vaccine For Dogs App 20160046950 - LANGLADE DEMOYEN; Pierre ;   et al. | 2016-02-18 |
Differential amplification of mutant nucleic acids by PCR in a mixture of nucleic acids Grant 8,541,206 - Wain-Hobson , et al. September 24, 2 | 2013-09-24 |
Nucleic acid probe of human immunodeficiency virus type 1 (HIV-1), and a method and kit employing this probe for detecting the presence of nucleic acid of HIV-1 Grant 8,507,196 - Alizon , et al. August 13, 2 | 2013-08-13 |
Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV) Grant 8,329,396 - Alizon , et al. December 11, 2 | 2012-12-11 |
APOBEC3 mediated DNA editing Grant 8,288,094 - Wain-Hobson , et al. October 16, 2 | 2012-10-16 |
Apobec3 Mediated Dna Editing App 20120073003 - Wain-Hobson; Simon ;   et al. | 2012-03-22 |
Differential Amplification Of Mutant Nucleic Acids By Pcr In A Mixture Of Nucleic Acids App 20110003282 - Wain-Hobson; Simon ;   et al. | 2011-01-06 |
Nucleic acids obtained from LAV.sub.MAL, a variant African AIDS virus Grant 7,767,800 - Alizon , et al. August 3, 2 | 2010-08-03 |
HIV-1 DNA fragments that hybridize to genomic HIV-1DNA Grant 7,626,013 - Alizon , et al. December 1, 2 | 2009-12-01 |
Apobec3 Mediated Dna Editing App 20090260090 - Wain-Hobson; Simon ;   et al. | 2009-10-15 |
Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity Grant 7,585,619 - Alizon , et al. September 8, 2 | 2009-09-08 |
Hiv Recombinant Vaccine App 20090142371 - Wain-Hobson; Simon ;   et al. | 2009-06-04 |
Recombinant HBsAg virus-like particles containing polyepitopes of interest, their production and use App 20080171062 - Sala-Schaeffer; Monica ;   et al. | 2008-07-17 |
Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use App 20080166785 - Sala-Schaeffer; Monica ;   et al. | 2008-07-10 |
Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA Grant 7,351,412 - Alizon , et al. April 1, 2 | 2008-04-01 |
Differential amplification of mutant nucleic acids by PCR in a mixure of nucleic acids App 20070154892 - Wain-Hobson; Simon ;   et al. | 2007-07-05 |
DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) Grant 7,232,654 - Chermann , et al. June 19, 2 | 2007-06-19 |
Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) Grant 7,217,508 - Wain-Hobson , et al. May 15, 2 | 2007-05-15 |
HIV recombinant vaccine App 20070065852 - Wain-Hobson; Simon ;   et al. | 2007-03-22 |
DNA sequences and peptides of human immunodeficiency virus (HIV-1) Grant 7,119,181 - Alizon , et al. October 10, 2 | 2006-10-10 |
Antibodies against antigens of human immunodeficiency virus (HIV-1) Grant 7,045,130 - Alizon , et al. May 16, 2 | 2006-05-16 |
Variant of LAV viruses Grant 7,029,679 - Alizon , et al. April 18, 2 | 2006-04-18 |
Variant of LAV viruses Grant 6,951,648 - Alizon , et al. October 4, 2 | 2005-10-04 |
Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA Grant 6,894,152 - Alizon , et al. May 17, 2 | 2005-05-17 |
Variant of LAV viruses Grant 6,730,304 - Alizon , et al. May 4, 2 | 2004-05-04 |
Human deficiency virus type-1 (HIV-1) peptide encoded by the VIF gene Grant 6,706,268 - Alizon , et al. March 16, 2 | 2004-03-16 |
Variant of LAV viruses App 20030224352 - Alizon, Marc ;   et al. | 2003-12-04 |
Variant of LAV viruses Grant 6,635,752 - Alizon , et al. October 21, 2 | 2003-10-21 |
HIV recombinant vaccine App 20030175693 - Wain-Hobson, Simon ;   et al. | 2003-09-18 |
Variant of LAV viruses App 20020177128 - Alizon, Marc ;   et al. | 2002-11-28 |
Variant of LAV viruses App 20020086285 - Alizon, Marc ;   et al. | 2002-07-04 |
Variant of LAV viruses App 20020076691 - Alizon, Marc ;   et al. | 2002-06-20 |
Variant of LAV viruses App 20020022033 - Alizon, Marc ;   et al. | 2002-02-21 |
Method for hypermutagenesis of nucleotides Grant 5,843,730 - Wain-Hobson , et al. December 1, 1 | 1998-12-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.